Minato-ku, Japan

Tsuneo Matsumoto



Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tokyo, JP (1995)
  • Minato-ku, JP (2011)

Company Filing History:


Years Active: 1995-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tsuneo Matsumoto

Introduction

Tsuneo Matsumoto is a notable inventor based in Minato-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Matsumoto's work has had a meaningful impact on medical science.

Latest Patents

Matsumoto's latest patents include an acid addition salt of irinotecan. This invention is directed to an irinotecan acid addition salt formed through the addition of various acids, such as sulfuric acid, nitric acid, and citric acid, among others. The method for producing this salt is noteworthy as it requires no heating process during drug preparation, resulting in an aqueous drug product where the salt is stably dissolved. Another significant patent involves a thrombolytic peptide, its production, and its application as a thrombolytic agent.

Career Highlights

Tsuneo Matsumoto is associated with Kabushiki Kaisha Yakult Honsha, a company known for its commitment to health and wellness through innovative products. His work at this organization has allowed him to focus on developing pharmaceutical solutions that address critical health issues.

Collaborations

Matsumoto has collaborated with esteemed colleagues such as Osamu Matsuo and Masashi Sakai. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical field.

Conclusion

In summary, Tsuneo Matsumoto is a distinguished inventor whose contributions to pharmaceutical innovations are noteworthy. His patents reflect a commitment to improving drug formulations and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…